Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 16, Issue 8, Pages 963-972
Publisher
Informa UK Limited
Online
2017-06-23
DOI
10.1080/14740338.2017.1346082
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rituximab versus fingolimod after natalizumab in multiple sclerosis patients
- (2016) Peter Alping et al. ANNALS OF NEUROLOGY
- Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod
- (2016) M. E. Evangelopoulos et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation
- (2016) Bianca Weinstock-Guttman et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry
- (2016) Luca Prosperini et al. PLoS One
- Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
- (2015) Maria Pia Amato et al. CNS DRUGS
- Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children
- (2015) Giovanna Vitaliti et al. Expert Review of Neurotherapeutics
- Progressive Multifocal Leukoencephalopathy
- (2015) Padmaja Sudhakar et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Immunosuppressive drugs and fertility
- (2015) Clara Leroy et al. Orphanet Journal of Rare Diseases
- Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children
- (2015) Giovanna Vitaliti et al. Expert Review of Neurotherapeutics
- Natalizumab-induced hepatic injury: A case report and review of literature
- (2015) A Antezana et al. Multiple Sclerosis and Related Disorders
- Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
- (2015) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Progressive multifocal leukoencephalopathy: current treatment options and future perspectives
- (2015) Dejan Pavlovic et al. Therapeutic Advances in Neurological Disorders
- Normal outcome of pregnancy with ongoing treatment with natalizumab
- (2014) J. Fagius et al. ACTA NEUROLOGICA SCANDINAVICA
- Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy
- (2014) Michael N. Khoury et al. ANNALS OF NEUROLOGY
- Progressive multifocal leukoencephalopathy after natalizumab discontinuation: Few and true?
- (2014) Mike P. Wattjes et al. ANNALS OF NEUROLOGY
- Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
- (2014) Tatiana Plavina et al. ANNALS OF NEUROLOGY
- MRI pattern in asymptomatic natalizumab-associated PML
- (2014) Mike P Wattjes et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study
- (2014) Neda Ebrahimi et al. Multiple Sclerosis Journal
- Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study
- (2014) P. O'Connor et al. NEUROLOGY
- Multiple Sclerosis and Pregnancy: Current Considerations
- (2014) Ioan Buraga et al. TheScientificWorldJOURNAL
- Risk for Nevus Transformation and Melanoma Proliferation and Invasion During Natalizumab Treatment
- (2014) Momen Pharaon et al. JAMA Dermatology
- Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab
- (2014) Marinella Clerico et al. JAMA Neurology
- Natalizumab Use During the Third Trimester of Pregnancy
- (2014) Aiden Haghikia et al. JAMA Neurology
- Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients
- (2014) Francesca Sangalli et al. Multiple Sclerosis and Related Disorders
- Progressive multifocal leukoencephalopathy in patients with multiple sclerosis
- (2013) Kelly J. Baldwin et al. CURRENT OPINION IN NEUROLOGY
- Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era
- (2013) J. L. Casado et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort
- (2013) O. Outteryck et al. EUROPEAN JOURNAL OF NEUROLOGY
- Central nervous system lymphoma associated with natalizumab
- (2013) Angelika Na et al. JOURNAL OF CLINICAL NEUROSCIENCE
- A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes
- (2013) David B. Clifford et al. JOURNAL OF NEUROVIROLOGY
- PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section
- (2013) J. R. Berger et al. NEUROLOGY
- Natalizumab-associated complication? First case of peripheral T cell lymphoma
- (2012) Jeffrey Schowinsky et al. ACTA NEUROPATHOLOGICA
- Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy
- (2012) Tarek A. Yousry et al. ANNALS OF NEUROLOGY
- Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain
- (2012) M. W. Ferenczy et al. CLINICAL MICROBIOLOGY REVIEWS
- Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies
- (2012) Dirk Mentzer et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The effect of plasma exchange on serum anti-JC virus antibodies
- (2012) Meena Subramanyam et al. Multiple Sclerosis Journal
- Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
- (2012) Per Soelberg Sørensen et al. Multiple Sclerosis Journal
- Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance
- (2012) N. F. Blair et al. NEUROLOGY
- Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review
- (2012) E. Lu et al. NEUROLOGY
- Pulse monthly steroids during an elective interruption of natalizumab: a post-marketing study
- (2011) G. Borriello et al. EUROPEAN JOURNAL OF NEUROLOGY
- Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
- (2011) K. W. Rammohan et al. NEUROLOGY
- Immune reconstitution inflammatory syndrome in natalizumab-associated PML
- (2011) I. L. Tan et al. NEUROLOGY
- Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
- (2011) P. Vermersch et al. NEUROLOGY
- Progressive multifocal leukoencephalopathy: clinical and molecular aspects
- (2011) Eleonora Tavazzi et al. REVIEWS IN MEDICAL VIROLOGY
- Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated
- (2010) Joep Killestein et al. ANNALS OF NEUROLOGY
- Considerations on discontinuing natalizumab for the treatment of multiple sclerosis
- (2010) Joseph R. Berger et al. ANNALS OF NEUROLOGY
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
- (2010) Chen S Tan et al. LANCET NEUROLOGY
- Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study
- (2010) F. Sangalli et al. NEUROLOGICAL SCIENCES
- Association of melanoma and natalizumab therapy in the Italian MS population: a second case report
- (2010) A. Laroni et al. NEUROLOGICAL SCIENCES
- Natalizumab and central nervous system lymphoma: No clear association
- (2009) Carmen Bozic et al. ANNALS OF NEUROLOGY
- Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons
- (2009) Christian Wüthrich et al. ANNALS OF NEUROLOGY
- Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro
- (2009) M. Brickelmaier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mirtazapine Use in Human Immunodeficiency Virus–Infected Patients With Progressive Multifocal Leukoencephalopathy
- (2009) Deanna Cettomai et al. ARCHIVES OF NEUROLOGY
- Progressive multifocal leukoencephalopathy in HIV-1 infection
- (2009) Paola Cinque et al. LANCET INFECTIOUS DISEASES
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
- (2009) Eva Havrdova et al. LANCET NEUROLOGY
- PML-IRIS in patients with HIV infection: Clinical manifestations and treatment with steroids
- (2009) K. Tan et al. NEUROLOGY
- Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function
- (2009) B. O. Khatri et al. NEUROLOGY
- Getting specific: monoclonal antibodies in multiple sclerosis
- (2008) Andreas Lutterotti et al. LANCET NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now